Researcher profile · Semantic Scholar

J. Reischl

h-index: 14
Works: 31
Citations: 1,349

Most-cited papers

Genomewide meta-analysis identifies novel multiple sclerosis susceptibility loci
N. Patsopoulos, F. Esposito, J. Reischl, S. Lehr +68 more
2011Annals of Neurology354 citations Open access
Semantic Scholar
Integrating genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility
P. De Jager, Lori B. Chibnik, Jing Cui, J. Reischl +14 more
2009Lancet Neurology273 citations Open access
Semantic Scholar
Increased expression of Wnt5a in psoriatic plaques.
J. Reischl, S. Schwenke, J. Beekman, U. Mrowietz +2 more
2007Journal of Investigative Dermatology174 citations Open access
Semantic Scholar
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls
H. Barthel, J. Luthardt, G. Becker, M. Patt +14 more
2011European Journal of Nuclear Medicine and Molecular Imaging103 citations
Semantic Scholar
AKT1E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection
M. Rudolph, T. Anzeneder, A. Schulz, G. Beckmann +7 more
2016BMC Cancer90 citations Open access
Semantic Scholar
Usability of deep learning and H&E images predict disease outcome-emerging tool to optimize clinical trials
Talha Qaiser, Ching-Yi Lee, Michel Vandenberghe, J. Yeh +4 more
2022npj Precision Oncology54 citations Open access
Semantic Scholar
Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology
L. Landeck, C. Kneip, J. Reischl, K. Asadullah
2016Experimental Dermatology47 citations Open access
Semantic Scholar
Recovery of microarray-quality RNA from frozen EDTA blood samples.
J. Beekman, J. Reischl, D. Henderson, David Bauer +4 more
2009Journal of pharmacological and toxicological methods36 citations
Semantic Scholar
Phenotypic suppression of empty spiracles is prevented by buttonhead
Frieder Schöck, J. Reischl, E. Wimmer, Heike Taubert +2 more
2000Nature33 citations
Semantic Scholar
Persistence of Hunchback in the terminal region of the Drosophila blastoderm embryo impairs anterior development.
Florence Janody, J. Reischl, Nathalie Dostatni
2000Development32 citations
Semantic Scholar
Separable transcriptional regulatory domains within Otd control photoreceptor terminal differentiation events
Elizabeth C. McDonald, Baotong Xie, M. Workman, Mark Charlton-Perkins +5 more
2010Developmental Biology26 citations Open access
Semantic Scholar
Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial.
M. Teufel, S. Schwenke, H. Seidel, G. Beckmann +16 more
201525 citations
Semantic Scholar
Eukaryotic RNA polymerase subunit RPB8 is a new relative of the OB family
S. Krapp, G. Kelly, J. Reischl, R. Weinzierl +1 more
1998Nature Structural Biology22 citations
Semantic Scholar
Biological response genes after single dose administration of interferon beta-1b to healthy male volunteers.
J. Hilpert, J. Beekman, S. Schwenke, K. Kowal +6 more
2008Journal of Neuroimmunology19 citations
Semantic Scholar
Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies
H. Hartung, B. Kieseier, D. Goodin, B. Arnason +15 more
2012Journal of Neuroinflammation12 citations Open access
Semantic Scholar
Analysis of plasma protein biomarkers from the phase 3 CONCUR study of regorafenib in Asian patients with metastatic colorectal cancer (mCRC).
M. Teufel, J. Kalmus, M. Rutstein, K. Koechert +10 more
20169 citations
Semantic Scholar
Key factors for successful data integration in biomarker research
A. Elefsinioti, Tanja Bellaire, Albert Wang, Karsten Quast +6 more
2016Nature reviews. Drug discovery9 citations
Semantic Scholar
Hybrid Aggregation Network for Survival Analysis from Whole Slide Histopathological Images
Jia-Ren Chang, Ching-Yi Lee, Chi-Chung Chen, J. Reischl +2 more
2021International Conference on Medical Image Computing and Computer-Assisted Intervention8 citations
Semantic Scholar
Collaboration for success: the value of strategic col-laborations for precision medicine and biomarker discovery
L. Landeck, M. Lessl, J. Reischl, A. Busch +4 more
20167 citations Open access
Semantic Scholar
Pharmacogenetic research and data protection – challenges and solutions
J. Reischl, M. Schröder, N. Luttenberger, D. Petrov +3 more
2006The Pharmacogenomics Journal5 citations
Semantic Scholar
2013 Analysis of biomarkers in circulating tumor DNA from the phase 3 CONCUR study of regorafenib in Asian patients with metastatic colorectal cancer (mCRC): Correlation with clinical outcome
M. Teufel, J. Kalmus, M. Rutstein, K. Köchert +10 more
20154 citations
Semantic Scholar
Design of Individual Donor Feedback Processes in Biobank Research
N. Luttenberger, R. Kollek, J. Reischl, C. Stürzebecher
2006GI Jahrestagung4 citations
Semantic Scholar
Abstract 5239: KRAS wild-type status as detected by circulating tumor DNA analysis may be a prognostic or predictive factor for clinical benefit in patients with unresectable, locally advanced or metastatic pancreatic cancer (PC) treated with the MEK inhibitor refametin
M. Teufel, J. Van Laethem, H. Riess, M. Giurescu +6 more
20152 citations
Semantic Scholar
Abstract 5252: Liquid biopsies to prospectively select patients withKRASorNRASmutant hepatocellular carcinoma (HCC) in two phase II studies with Refametinib
H. Krissel, A. Hennig, Da-ning Zhang, R. Ito +8 more
20151 citations
Semantic Scholar
Abstract 569: AKT1 (E17K) mutation: coexistence with oncogenic alterations, prevalence, and correlation to clinical parameter in a large series of breast cancer patients
M. Rudolph, T. Anzeneder, M. Ocker, E. Lagkadinou +11 more
20141 citations
Semantic Scholar
AKT1E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection
M. Rudolph, T. Anzeneder, A. Schulz, G. Beckmann +7 more
2016BMC Cancer0 citations Open access
Semantic Scholar
Abstract 929: Tumor genotyping in the phase III GRID study of regorafenib vs placebo in tyrosine kinase inhibitor (TKI)-refractory GIST: Detection of KIT mutations in circulating tumor DNA comparing digital PCR and massive parallel sequencing
M. Jeffers, H. Seidel, S. Schwenke, J. Reischl +4 more
20150 citations
Semantic Scholar
Abstract B42: RAS mutations detected by cell-free plasma DNA (BEAMing) assay may portend a favorable response to refametinib +/- sorafenib in hepatocellular carcinoma
H. Lim, H. Krissel, M. Teufel, F. Puehler +4 more
20140 citations
Semantic Scholar
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci | NOVA. The University of Newcastle's Digital Repository
N. Patsopoulos, P. D. de Bakker, L. Kappos, Danny Miller +68 more
20110 citations
Semantic Scholar
P2‐002: [18F]BAY 94‐9172 PET ‐ Towards in vivo quantification of brain β‐amyloid plaque load in Alzheimer disease
O. Sabri, H. Barthel, G. Becker, J. Luthardt +12 more
20090 citations Open access
Semantic Scholar
YEAST RNA POLYMERASE SUBUNIT RPB8, NMR, MINIMIZED AVERAGE STRUCTURE, ALPHA CARBONS ONLY
S. Krapp, G. Kelly, J. Reischl, R. Weinzierl +1 more
19990 citations
Semantic Scholar

David Bauer

×5

R. Sandbrink×5

S. Schwenke×5

S. Lehr×4

A. Schulz×4

G. Beckmann×4

M. Jeffers×4

M. Rutstein×4